Foley Hoag LLP

Mayer Brown advised Igneo Infrastructure Partners. Foley Hoag advised Soltage on the transation. Igneo Infrastructure Partners, a global infrastructure investment manager, announced the acquisition of a...

Foley Hoag LLP represented PSG on the deal. PSG, a leading growth firm partnering with software and technology-enabled service companies to help accelerate their growth, acted...

Foley Hoag LLP advised the Federal Democratic Republic of Nepal on the deal. Nepal obtained a victory in US$422 million claim commenced by Axiata Investments UK...

Foley Hoag LLP represented Modern Hydrogen on the deal. Modern Hydrogen (formerly Modern Electron), a sustainable heat and hydrogen company, announced an oversubscribed $32.8 million Series...

Foley Hoag represented Ginkgo Bioworks on the deal. Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated...

Foley Hoag LLP represented Purdue Research Foundation on the deal. Purdue Research Foundation, a private not-for-profit institute to advance the research of Purdue University, announced the...

Foley Hoag LLP advised Genialis on the deal. Genialis, a computational precision medicine company, announced its $13M Series A financing led by Debiopharm Innovatoin Fund and Taiwania...

Foley Hoag advised Daewoong Pharmaceutical on the deal. South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused...

Foley Hoag advised Lantheus Holdings on the deal. Lantheus Holdings (Nasdaq: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions,...

Holland & Hart represented Holcim on the deal. Holcim, a global leader in innovative and sustainable building solutions, announced the acquisition of the sand and aggregates quarries...

Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...

Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...